| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
abraxas 1, BRCA1 A complex subunit | 0.760 | 0.269 | 5.1E-07 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.110 | None | 1.000 | 160 | 257 | 1991 | 2017 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.100 | None | 1.000 | 233 | 561 | 1989 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BLM RecQ like helicase | 0.535 | 0.808 | 1.5E-15 |
|
group | 0.100 | None | 1.000 | 26 | 10 | 1995 | 2016 | ||||||||
|
bone morphogenetic protein receptor type 1A | 0.522 | 0.731 | 0.90 |
|
group | 0.110 | None | 1.000 | 19 | 60 | 1997 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.180 | None | 1.000 | 19 | 23 | 2011 | 2019 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
group | 0.100 | None | 1.000 | 28 | 105 | 2003 | 2017 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.150 | None | 1.000 | 749 | 705 | 1975 | 2019 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
group | 0.100 | None | 1.000 | 56 | 145 | 2004 | 2017 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.130 | None | 1.000 | 704 | 1021 | 1996 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.130 | None | 1.000 | 68 | 87 | 1994 | 2019 | ||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.100 | None | 0 | 1 | ||||||||||||
|
cell division cycle 73 | 0.543 | 0.615 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2014 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.100 | None | 1.000 | 106 | 133 | 1999 | 2019 | ||||||||
|
chromosome 11 open reading frame 65 | 0.670 | 0.462 | 2.0E-14 |
|
group | 0.100 | None | 1.000 | 159 | 220 | 1996 | 2018 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.110 | None | 1.000 | 135 | 49 | 1994 | 2017 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.120 | None | 1.000 | 13 | 90 | 2009 | 2016 | ||||||||
|
DNA polymerase delta 1, catalytic subunit | 0.507 | 0.769 | 2.4E-06 |
|
group | 0.100 | None | 1.000 | 7 | 2 | 2006 | 2017 | ||||||||
|
DNA polymerase epsilon, catalytic subunit | 0.526 | 0.731 | 8.0E-27 |
|
group | 0.100 | None | 1.000 | 6 | 2 | 1996 | 2015 | ||||||||
|
exostosin glycosyltransferase 2 | 0.576 | 0.654 | 1.3E-09 |
|
group | 0.100 | None | 0 | 1 |